An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
Saved in:
| Title: | An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. |
|---|---|
| Authors: | Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Whittle SB; Texas Children's Cancer and Hematology Centers, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Surdez D; Bone Sarcoma Research Laboratory, Balgrist University Hospital, University of Zurich, Zurich, Switzerland., Bailey KM; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC/Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Yustein JT; Texas Children's Cancer and Hematology Center and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, USA., Shlien A; Department of Laboratory Medicine and Pathobiology/Department of Paediatric Laboratory Medicine/Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Hayashi M; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA., Bishop AJR; Greehey Children's Cancer Research Institute and Department of Cell Systems and Anatomy, University of Texas Health at San Antonio, San Antonio, TX, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leavey PJ; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA., Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, and the Division of Pediatric Heme/Onc/BMT, The Ohio State University College of Medicine, Columbus, OH, USA., Kovar H; St. Anna Children´s Cancer Research Institute (CCRI) and Department Pediatrics Medical University of Vienna, Vienna, Austria., Delattre O; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, Paris, France., Grünewald TGP; Hopp-Children's Cancer Center (KiTZ), Heidelberg/Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK)/Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts RD; Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA., Toretsky JA; Departments of Oncology and Pediatrics, Georgetown University, Washington, DC, USA., Tirode F; Univ Lyon, Universite Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Centre Leon Berard, F-69008, Lyon, France., Gorlick R; Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Reed D; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL, USA., Lawlor ER; Seattle Children's Research Institute, University of Washington Medical School, Seattle, WA, USA., Grohar PJ; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. GROHARP@EMAIL.CHOP.EDU. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2022 Sep 17; Vol. 6 (1), pp. 65. Date of Electronic Publication: 2022 Sep 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-022-00307-2 |
